• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5 岁患儿因白细胞介素-36 受体拮抗剂(DITRA)缺乏导致严重头皮和指甲受累,使用司库奇尤单抗后迅速起效。

Rapid response to secukinumab in a 5-year-old with deficiency of the interleukin-36 receptor antagonist (DITRA) with severe scalp and nail involvement.

机构信息

Department of Dermatology, University of Hong Kong Shenzhen Hospital, Shenzhen, China.

出版信息

Pediatr Dermatol. 2021 Sep;38(5):1258-1263. doi: 10.1111/pde.14737. Epub 2021 Aug 2.

DOI:10.1111/pde.14737
PMID:34339530
Abstract

Deficiency of the interleukin-36 receptor antagonist (DITRA) is an autosomal recessive disease caused by mutations of the IL36RN gene. DITRA is characterized by acute generalized pustular psoriasis (GPP), fever, systemic inflammation, and leukocytosis. We report the case of a 5-year-old girl with severe scalp and nail involvement with a rapid response to secukinumab.

摘要

白细胞介素-36 受体拮抗剂(DITRA)缺乏症是一种常染色体隐性疾病,由 IL36RN 基因突变引起。DITRA 的特征是急性泛发性脓疱性银屑病(GPP)、发热、全身炎症和白细胞增多。我们报告了一例 5 岁女孩,头皮和指甲严重受累,对司库奇尤单抗有快速反应。

相似文献

1
Rapid response to secukinumab in a 5-year-old with deficiency of the interleukin-36 receptor antagonist (DITRA) with severe scalp and nail involvement.5 岁患儿因白细胞介素-36 受体拮抗剂(DITRA)缺乏导致严重头皮和指甲受累,使用司库奇尤单抗后迅速起效。
Pediatr Dermatol. 2021 Sep;38(5):1258-1263. doi: 10.1111/pde.14737. Epub 2021 Aug 2.
2
Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.成功使用司库奇尤单抗单药治疗难治性青少年泛发性脓疱型银屑病:一例病例报告及文献复习。
J Dermatol. 2018 Nov;45(11):1353-1356. doi: 10.1111/1346-8138.14636. Epub 2018 Sep 19.
3
Cutaneous findings and treatments in deficiency of interleukin-36 receptor antagonist (DITRA): A review of the literature.白细胞介素-36 受体拮抗剂(DITRA)缺乏症的皮肤表现和治疗:文献复习。
Exp Dermatol. 2024 Jan;33(1):e14934. doi: 10.1111/exd.14934. Epub 2023 Sep 19.
4
Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy.使用司库奇尤单抗单药治疗一例 3 岁女童泛发性脓疱型银屑病获得成功。
Pediatr Dermatol. 2021 Sep;38(5):1366-1367. doi: 10.1111/pde.14795. Epub 2021 Sep 13.
5
Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA.Toll 样受体 4 拮抗剂 TAK-242 抑制 DITRA 的自身炎症症状。
J Autoimmun. 2017 Jun;80:28-38. doi: 10.1016/j.jaut.2017.01.007. Epub 2017 Feb 11.
6
Excellent response to secukinumab in an infant with severe generalized pustular psoriasis.婴幼儿严重泛发性脓疱型银屑病应用司库奇尤单抗后获得良好疗效。
J Dermatol. 2021 Jun;48(6):907-910. doi: 10.1111/1346-8138.15673. Epub 2021 Feb 4.
7
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents.儿童和青少年白细胞介素-36 受体拮抗剂缺乏症(DITRA)的生物治疗的范围综述。
Pediatr Rheumatol Online J. 2019 Jul 8;17(1):37. doi: 10.1186/s12969-019-0338-1.
8
Novel use of Autoinflammatory Diseases Activity Index (AIDAI) captures skin and extracutaneous features to help manage pediatric DITRA: A case report and a proposal for a modified disease activity index in autoinflammatory keratinization disorders.自身炎症性疾病活动指数(AIDAI)的新用途可捕捉皮肤和皮肤外特征,以帮助管理儿童DITRA:一例病例报告及自身炎症性角化障碍改良疾病活动指数的提议
Pediatr Dermatol. 2020 Jul;37(4):670-676. doi: 10.1111/pde.14155. Epub 2020 Apr 17.
9
Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series.中国白细胞介素-36 受体拮抗剂缺乏症(DITRA)妊娠患者使用生物制剂:病例系列研究。
Taiwan J Obstet Gynecol. 2024 May;63(3):405-408. doi: 10.1016/j.tjog.2024.02.001. Epub 2024 Mar 5.
10
Successful treatment with interleukin-17A antagonists of generalized pustular psoriasis in patients without IL36RN mutations.白细胞介素-17A 拮抗剂治疗无 IL36RN 突变的泛发性脓疱型银屑病患者获得成功。
J Dermatol. 2018 Jul;45(7):850-854. doi: 10.1111/1346-8138.14318. Epub 2018 Apr 14.

引用本文的文献

1
The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives.白细胞介素-17在全身自身炎症性疾病中的作用:机制与治疗前景
Clin Rev Allergy Immunol. 2025 Mar 12;68(1):27. doi: 10.1007/s12016-025-09042-5.